Colin Sandercock

Colin Sandercock

Corporate Officer/Principal bij CUE BIOPHARMA, INC.

Vermogen: 18 021 $ op 30-06-2026

69 jaar
Commercial Services
Consumer Services
Health Technology

Profiel

Colin G.
Sandercock
is Senior Vice President-Intellectual Property at Cue Biopharma, Inc. since 2026, with employment at the firm starting in 2017.
Formerly, Mr. Sandercock was Partner at Perkins Coie LLP from 2009 to 2017, Co-Chairman-Life Science Practice Group at Proskauer Rose LLP from 2006 to 2009, Co-Chairman-Intellectual Property Practice Group at Heller Ehrman LLP from 2000 to 2006, and Chairman-Chemical Practice Group at Foley & Lardner LLP from 1990 to 2000.
Education includes graduate degrees from the University of Pennsylvania in 1980 and The Catholic University of America in 1984, and an undergraduate degree from Moravian College in 1978.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
05-05-2026 571 ( 0,01% ) 18 021 $ 30-06-2026

Actieve functies van Colin Sandercock

BedrijvenFunctieBegin
CUE BIOPHARMA, INC. Corporate Officer/Principal 01-06-2026

Eerdere bekende functies van Colin Sandercock

BedrijvenFunctieEinde
Corporate Officer/Principal 01-11-2017
Corporate Officer/Principal 01-07-2009
Corporate Officer/Principal 01-01-2006
Corporate Officer/Principal 01-01-2000
Ervaring van Colin Sandercock in detail bekijken

Opleiding van Colin Sandercock

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

77

Eerstegraads connecties

8

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit8

Commercial Services

Commercial Services

Consumer Services

Commercial Services

Commercial Services

Consumer Services

Consumer Services

Health Technology

  1. Beurs
  2. Insiders
  3. Colin Sandercock